Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Parenthetical)

v3.23.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Accounts receivable allowance, net $ 268 $ 272
Preferred stock, par value (in usd per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Common stock, par value (in usd per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 16,478,253 3,570,894
Common stock, shares outstanding (in shares) 16,478,252 3,570,893
Treasury stock (in shares) 1 1
Series 4 Convertible Preferred Stock    
Preferred stock, shares authorized (in shares) 10,415 10,415
Preferred stock, shares issued (in shares) 1 1
Preferred stock, shares outstanding (in shares) 1 1
Series 5 Convertible Preferred Stock    
Preferred stock, shares authorized (in shares) 12,000 12,000
Preferred stock, shares issued (in shares) 126 126
Preferred stock, shares outstanding (in shares) 126 126